# Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer

> **NCT01654367** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Tianjin Medical University** · enrollment: 300 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Zoledronic Acid and Aromatase Inhibitors

## Key facts

- **NCT ID:** NCT01654367
- **Lead sponsor:** Tianjin Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2012-12
- **Final completion:** 2013-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2012-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01654367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01654367, "Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01654367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*